Your browser doesn't support javascript.
loading
From Waldenström's macroglobulinemia to aggressive diffuse large B-cell lymphoma: a whole-exome analysis of abnormalities leading to transformation.
Jiménez, C; Alonso-Álvarez, S; Alcoceba, M; Ordóñez, G R; García-Álvarez, M; Prieto-Conde, M I; Chillón, M C; Balanzategui, A; Corral, R; Marín, L A; Gutiérrez, N C; Puig, N; Sarasquete, M E; González, M; García-Sanz, R.
Afiliação
  • Jiménez C; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Alonso-Álvarez S; Hematology Department, Central University Hospital of Asturias, Oviedo, Spain.
  • Alcoceba M; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Ordóñez GR; Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca, Spain.
  • García-Álvarez M; DREAMgenics, Oviedo, Spain.
  • Prieto-Conde MI; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Chillón MC; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Balanzategui A; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Corral R; Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca, Spain.
  • Marín LA; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Gutiérrez NC; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Puig N; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • Sarasquete ME; Center for Biomedical Research in Network of Cancer (CIBERONC), Salamanca, Spain.
  • González M; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
  • García-Sanz R; Hematology Department, University Hospital of Salamanca and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
Blood Cancer J ; 7(8): e591, 2017 08 25.
Article em En | MEDLINE | ID: mdl-28841204
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Transformação Celular Neoplásica / Linfoma Difuso de Grandes Células B / Macroglobulinemia de Waldenstrom / Antígenos CD79 / Exoma / Mutação / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Transformação Celular Neoplásica / Linfoma Difuso de Grandes Células B / Macroglobulinemia de Waldenstrom / Antígenos CD79 / Exoma / Mutação / Proteínas de Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Cancer J Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha